SB 2246

  • Tennessee Senate Bill
  • 113th Regular Session (2023-2024)
  • Introduced in Senate Jan 31, 2024
  • Passed Senate Feb 01, 2024
  • House
  • Governor

Drugs, Prescription - As enacted, authorizes a healthcare provider licensed as a nurse or physician assistant to prescribe a buprenorphine product as approved by the FDA for use in recovery or medication-assisted treatment if certain criteria are met. - Amends TCA Title 33; Title 53; Title 63 and Title 68.

Votes


Actions


May 28, 2024

Senate

Comp. became Pub. Ch. 980

Apr 22, 2024

Senate

Companion House Bill substituted

Apr 19, 2024

Senate

Placed on Senate Regular Calendar for 4/22/2024

Apr 03, 2024

Senate

Recommended for passage with amendment/s, refer to Senate Calendar Committee Ayes 7, Nays 2 PNV 0

Mar 27, 2024

Senate

Placed on Senate Health and Welfare Committee calendar for 4/3/2024

Mar 20, 2024

Senate

Reset on Final calendar of Senate Health and Welfare Committee

Mar 13, 2024

Senate

Placed on Senate Health and Welfare Committee calendar for 3/19/2024

Feb 01, 2024

Senate

Passed on Second Consideration, refer to Senate Health and Welfare Committee

Jan 31, 2024

Senate

Introduced, Passed on First Consideration

Jan 30, 2024

Senate

Filed for introduction

Bill Text

Bill Text Versions Format
Current Version PDF
Amendment SA0985 PDF
Amendment HA0953 PDF

Related Documents

Document Format
Fiscal Memo for SA0985 (17307)
Fiscal Note

Sources

Data on Open States is updated periodically throughout the day from the official website of the Tennessee General Assembly.

If you notice any inconsistencies with these official sources, feel free to file an issue.